These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 26783250

  • 1. Ginsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagy.
    Yang Z, Zhao T, Liu H, Zhang L.
    Sci Rep; 2016 Jan 19; 6():19383. PubMed ID: 26783250
    [Abstract] [Full Text] [Related]

  • 2. Ginsenoside rh2 inhibits cancer stem-like cells in skin squamous cell carcinoma.
    Liu S, Chen M, Li P, Wu Y, Chang C, Qiu Y, Cao L, Liu Z, Jia C.
    Cell Physiol Biochem; 2015 Jan 19; 36(2):499-508. PubMed ID: 25966742
    [Abstract] [Full Text] [Related]

  • 3. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX, Qi Y, Zhang J, Liu Y, Xu WH, Xu J, Hu HG, Wu QY, Wang Y, Zhang JP.
    Oncotarget; 2016 Nov 29; 7(48):79544-79556. PubMed ID: 27783993
    [Abstract] [Full Text] [Related]

  • 4. 20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription.
    Li Q, Li B, Dong C, Wang Y, Li Q.
    Eur J Pharmacol; 2017 Nov 15; 815():173-180. PubMed ID: 28928088
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of autophagy potentiates anticancer property of 20(S)-ginsenoside Rh2 by promoting mitochondria-dependent apoptosis in human acute lymphoblastic leukaemia cells.
    Xia T, Wang J, Wang Y, Wang Y, Cai J, Wang M, Chen Q, Song J, Yu Z, Huang W, Fang J.
    Oncotarget; 2016 May 10; 7(19):27336-49. PubMed ID: 27027340
    [Abstract] [Full Text] [Related]

  • 6. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L, Wang X, Jia T, Wei W, Chua MS, So S.
    Oncotarget; 2015 Sep 22; 6(28):25390-401. PubMed ID: 26246473
    [Abstract] [Full Text] [Related]

  • 7. Anticancer effect of 20(S)-ginsenoside Rh2 on HepG2 liver carcinoma cells: Activating GSK-3β and degrading β-catenin.
    Shi Q, Shi X, Zuo G, Xiong W, Li H, Guo P, Wang F, Chen Y, Li J, Chen DL.
    Oncol Rep; 2016 Oct 22; 36(4):2059-70. PubMed ID: 27573179
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
    Liu M, Bamodu OA, Kuo KT, Lee WH, Lin YK, Wu ATH, M H, Tzeng YM, Yeh CT, Tsai JT.
    Am J Chin Med; 2018 Oct 22; 46(4):891-910. PubMed ID: 29792038
    [Abstract] [Full Text] [Related]

  • 9. Differentiation therapy of hepatocellular carcinoma by inhibiting the activity of AKT/GSK-3β/β-catenin axis and TGF-β induced EMT with sophocarpine.
    Zhang PP, Wang PQ, Qiao CP, Zhang Q, Zhang JP, Chen F, Zhang X, Xie WF, Yuan ZL, Li ZS, Chen YX.
    Cancer Lett; 2016 Jun 28; 376(1):95-103. PubMed ID: 26945965
    [Abstract] [Full Text] [Related]

  • 10. 20(S)-Ginsenoside Rh2 inhibits hepatocellular carcinoma by suppressing angiogenesis and the GPC3-mediated Wnt/β‑catenin signaling pathway.
    Xu L, Li J, Hou N, Han F, Sun X, Li Q.
    Acta Biochim Biophys Sin (Shanghai); 2024 May 25; 56(5):688-696. PubMed ID: 38584523
    [Abstract] [Full Text] [Related]

  • 11. Bruceine D inhibits hepatocellular carcinoma growth by targeting β-catenin/jagged1 pathways.
    Cheng Z, Yuan X, Qu Y, Li X, Wu G, Li C, Zu X, Yang N, Ke X, Zhou J, Xie N, Xu X, Liu S, Shen Y, Li H, Zhang W.
    Cancer Lett; 2017 Sep 10; 403():195-205. PubMed ID: 28645563
    [Abstract] [Full Text] [Related]

  • 12. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.
    Wang XH, Sun X, Meng XW, Lv ZW, Du YJ, Zhu Y, Chen J, Kong DX, Jin SZ.
    Oncol Rep; 2010 Oct 10; 24(4):1093-9. PubMed ID: 20811694
    [Abstract] [Full Text] [Related]

  • 13. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
    Qin X, Zhang H, Zhou X, Wang C, Zhang H, Zhang X, Ye L.
    Transl Res; 2007 Nov 10; 150(5):281-94. PubMed ID: 17964517
    [Abstract] [Full Text] [Related]

  • 14. Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma.
    Cheung PF, Cheung TT, Yip CW, Ng LW, Fung SW, Lo CM, Fan ST, Cheung ST.
    Oncotarget; 2016 Apr 19; 7(16):21644-57. PubMed ID: 26942873
    [Abstract] [Full Text] [Related]

  • 15. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
    Toh TB, Lim JJ, Hooi L, Rashid MBMA, Chow EK.
    J Hepatol; 2020 Jan 19; 72(1):104-118. PubMed ID: 31541681
    [Abstract] [Full Text] [Related]

  • 16. Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma.
    Zhang D, Ma X, Sun W, Cui P, Lu Z.
    Int J Clin Exp Pathol; 2015 Jan 19; 8(3):3386-94. PubMed ID: 26045876
    [Abstract] [Full Text] [Related]

  • 17. Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling.
    Liu F, Wu X, Jiang X, Qian Y, Gao J.
    J Exp Clin Cancer Res; 2018 Jun 25; 37(1):122. PubMed ID: 29940988
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
    Li Y, Jiang F, Liu Q, Shen J, Wang X, Li Z, Zhang J, Lu X.
    Toxicol Sci; 2015 Jan 25; 143(1):156-64. PubMed ID: 25304214
    [Abstract] [Full Text] [Related]

  • 19. Ginsenoside Rh2 inhibits prostate cancer cell growth through suppression of microRNA-4295 that activates CDKN1A.
    Gao Q, Zheng J.
    Cell Prolif; 2018 Jun 25; 51(3):e12438. PubMed ID: 29457293
    [Abstract] [Full Text] [Related]

  • 20. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells.
    Fan Q, Yang L, Zhang X, Ma Y, Li Y, Dong L, Zong Z, Hua X, Su D, Li H, Liu J.
    J Exp Clin Cancer Res; 2018 Jan 19; 37(1):9. PubMed ID: 29351758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.